Cecha
Hydronephrosis
Severe distention of the kidney with dilation of the renal pelvis and calices.
Podsumowanie
- Układ organizmu
- Abnormality of the genitourinary system
Genom referencyjnyGRCh38hg38
Pozycje na stronach genów i wariantów zależą od tego wyboru, w tej przeglądarce.
Read the genes linked to Hydronephrosis, and the rest of your genome, with one test.
Od 449 $Bezpłatna wysyłka · Wyniki w ciągu 6–8 tygodni
Zamawiam Genome Test282 genów powiązanych z Hydronephrosis
Zmiany w tych genach powodują rzadkie choroby, w których występuje Hydronephrosis. Większość osób z tą cechą nie ma żadnej z tych chorób, a gen z tej listy nic nie mówi o czyimkolwiek własnym genomie.
| Gen | Jak często występuje | Choroby |
|---|---|---|
| AMOTL1angiomotin like 1 | Zawsze | W 1 chorobie |
| ARNT2aryl hydrocarbon receptor nuclear translocator 2 | Zawsze | W 1 chorobie |
| B3GALT6beta-1,3-galactosyltransferase 6 | Zawsze | W 1 chorobie |
| CACHD1cache domain containing 1 | Zawsze | W 1 chorobie |
| CD81CD81 molecule | Zawsze | W 1 chorobie |
| CIROZciliated left-right organizer protein containing ZP-N domains | Zawsze | W 1 chorobie |
| CREBBPCREB binding lysine acetyltransferase | Zawsze | W 3 chorobach |
| DYRK1Adual specificity tyrosine phosphorylation regulated kinase 1A | Zawsze | W 2 chorobach |
| EN1engrailed homeobox 1 | Zawsze | W 1 chorobie |
| EP300EP300 lysine acetyltransferase | Zawsze | W 2 chorobach |
| FBXL4F-box and leucine rich repeat protein 4 | Zawsze | W 1 chorobie |
| FLNAfilamin A | Zawsze | W 7 chorobach |
| GPC3glypican 3 | Zawsze | W 2 chorobach |
| HOXA13homeobox A13 | Zawsze | W 1 chorobie |
| IARS1isoleucyl-tRNA synthetase 1 | Zawsze | W 2 chorobach |
| JKAMPJNK1/MAPK8 associated membrane protein | Zawsze | W 1 chorobie |
| KIAA0753KIAA0753 | Zawsze | W 1 chorobie |
| LMOD1leiomodin 1 | Zawsze | W 1 chorobie |
| MAU2MAU2 sister chromatid cohesion factor | Zawsze | W 1 chorobie |
| MED12mediator complex subunit 12 | Zawsze | W 2 chorobach |
| MED16mediator complex subunit 16 | Zawsze | W 1 chorobie |
| MYCNMYCN proto-oncogene, bHLH transcription factor | Zawsze | W 2 chorobach |
| NCAPG2non-SMC condensin II complex subunit G2 | Zawsze | W 1 chorobie |
| NFIAnuclear factor I A | Zawsze | W 1 chorobie |
| NIPBLNIPBL cohesin loading factor | Zawsze | W 1 chorobie |
| PIGAphosphatidylinositol glycan anchor biosynthesis class A | Zawsze | W 1 chorobie |
| POLR1ARNA polymerase I subunit A | Zawsze | W 1 chorobie |
| PTBP1polypyrimidine tract binding protein 1 | Zawsze | W 1 chorobie |
| SGSM3small G protein signaling modulator 3 | Zawsze | W 1 chorobie |
| TOP2BDNA topoisomerase II beta | Zawsze | W 1 chorobie |
| UGGT1UDP-glucose glycoprotein glucosyltransferase 1 | Zawsze | W 1 chorobie |
| CDKN1Ccyclin dependent kinase inhibitor 1C | Bardzo często (80–99%) | W 1 chorobie |
| KAT6Blysine acetyltransferase 6B | Bardzo często (80–99%) | W 2 chorobach |
| POLEDNA polymerase epsilon, catalytic subunit | Bardzo często (80–99%) | W 1 chorobie |
| RNU4ATACRNA, U4atac small nuclear | Bardzo często (80–99%) | W 1 chorobie |
| WFS1wolframin ER transmembrane glycoprotein | Bardzo często (80–99%) | W 1 chorobie |
| ACTBactin beta | Często (30–79%) | W 1 chorobie |
| ACTG1actin gamma 1 | Często (30–79%) | W 1 chorobie |
| ACTG2actin gamma 2, smooth muscle | Często (30–79%) | W 2 chorobach |
| BBS12Bardet-Biedl syndrome 12 | Często (30–79%) | W 2 chorobach |
Pokaż jeszcze 242 genów
| Gen | Jak często występuje | Choroby |
|---|---|---|
| BCL11ABCL11 transcription factor A | Często (30–79%) | W 1 chorobie |
| BCORBCL6 corepressor | Często (30–79%) | W 1 chorobie |
| BNC2basonuclin zinc finger protein 2 | Często (30–79%) | W 1 chorobie |
| CCNQcyclin Q | Często (30–79%) | W 1 chorobie |
| CHRNA3cholinergic receptor nicotinic alpha 3 subunit | Często (30–79%) | W 1 chorobie |
| COG1component of oligomeric golgi complex 1 | Często (30–79%) | W 1 chorobie |
| COG7component of oligomeric golgi complex 7 | Często (30–79%) | W 1 chorobie |
| CPT2carnitine palmitoyltransferase 2 | Często (30–79%) | W 1 chorobie |
| DLG5discs large MAGUK scaffold protein 5 | Często (30–79%) | W 1 chorobie |
| DYNC2H1dynein cytoplasmic 2 heavy chain 1 | Często (30–79%) | W 1 chorobie |
| DYNC2I1dynein 2 intermediate chain 1 | Często (30–79%) | W 1 chorobie |
| DYNC2I2dynein 2 intermediate chain 2 | Często (30–79%) | W 1 chorobie |
| EMILIN1elastin microfibril interfacer 1 | Często (30–79%) | W 1 chorobie |
| ERI1exoribonuclease 1 | Często (30–79%) | W 2 chorobach |
| GATA3GATA binding protein 3 | Często (30–79%) | W 1 chorobie |
| GEMIN4gem nuclear organelle associated protein 4 | Często (30–79%) | W 1 chorobie |
| GPC4glypican 4 | Często (30–79%) | W 1 chorobie |
| HNRNPKheterogeneous nuclear ribonucleoprotein K | Często (30–79%) | W 3 chorobach |
| HPSE2heparanase 2 (inactive) | Często (30–79%) | W 2 chorobach |
| IFT80intraflagellar transport 80 | Często (30–79%) | W 1 chorobie |
| ITGA6integrin subunit alpha 6 | Często (30–79%) | W 1 chorobie |
| ITGB4integrin subunit beta 4 | Często (30–79%) | W 2 chorobach |
| LRIG2leucine rich repeats and immunoglobulin like domains 2 | Często (30–79%) | W 2 chorobach |
| LRRC7leucine rich repeat containing 7 | Często (30–79%) | W 1 chorobie |
| LTBP4latent transforming growth factor beta binding protein 4 | Często (30–79%) | W 1 chorobie |
| MAP3K7mitogen-activated protein kinase kinase kinase 7 | Często (30–79%) | W 1 chorobie |
| MKKSMKKS centrosomal shuttling protein | Często (30–79%) | W 3 chorobach |
| MYOD1myogenic differentiation 1 | Często (30–79%) | W 1 chorobie |
| NAA10N-alpha-acetyltransferase 10, NatA catalytic subunit | Często (30–79%) | W 1 chorobie |
| PEX1peroxisomal biogenesis factor 1 | Często (30–79%) | W 2 chorobach |
| PEX10peroxisomal biogenesis factor 10 | Często (30–79%) | W 1 chorobie |
| PEX11Bperoxisomal biogenesis factor 11 beta | Często (30–79%) | W 1 chorobie |
| PEX12peroxisomal biogenesis factor 12 | Często (30–79%) | W 1 chorobie |
| PEX13peroxisomal biogenesis factor 13 | Często (30–79%) | W 1 chorobie |
| PEX14peroxisomal biogenesis factor 14 | Często (30–79%) | W 1 chorobie |
| PEX16peroxisomal biogenesis factor 16 | Często (30–79%) | W 1 chorobie |
| PEX19peroxisomal biogenesis factor 19 | Często (30–79%) | W 1 chorobie |
| PEX2peroxisomal biogenesis factor 2 | Często (30–79%) | W 1 chorobie |
| PEX26peroxisomal biogenesis factor 26 | Często (30–79%) | W 1 chorobie |
| PEX3peroxisomal biogenesis factor 3 | Często (30–79%) | W 1 chorobie |
| PEX5peroxisomal biogenesis factor 5 | Często (30–79%) | W 1 chorobie |
| PEX6peroxisomal biogenesis factor 6 | Często (30–79%) | W 1 chorobie |
| POLR3ARNA polymerase III subunit A | Często (30–79%) | W 1 chorobie |
| PPP3CAprotein phosphatase 3 catalytic subunit alpha | Często (30–79%) | W 1 chorobie |
| PSKH1protein serine kinase H1 | Często (30–79%) | W 1 chorobie |
| RAD51CRAD51 paralog C | Często (30–79%) | W 1 chorobie |
| RELREL proto-oncogene, NF-kB subunit | Często (30–79%) | W 1 chorobie |
| ROR2ROR family WNT receptor 2 | Często (30–79%) | W 2 chorobach |
| SETBP1SET binding protein 1 | Często (30–79%) | W 2 chorobach |
| SOX17SRY-box transcription factor 17 | Często (30–79%) | W 1 chorobie |
| TP63tumor protein p63 | Często (30–79%) | W 2 chorobach |
| WDR35WD repeat domain 35 | Często (30–79%) | W 1 chorobie |
| XPO1exportin 1 | Często (30–79%) | W 1 chorobie |
| ALG9ALG9 alpha-1,2-mannosyltransferase | Czasami (5–29%) | W 1 chorobie |
| APCAPC regulator of Wnt signaling pathway | Czasami (5–29%) | W 1 chorobie |
| ARL3ARF like GTPase 3 | Czasami (5–29%) | W 1 chorobie |
| ARL6ARF like GTPase 6 | Czasami (5–29%) | W 1 chorobie |
| ATRXATRX chromatin remodeler | Czasami (5–29%) | W 2 chorobach |
| B3GLCTbeta 3-glucosyltransferase | Czasami (5–29%) | W 2 chorobach |
| BAP1BRCA1 associated deubiquitinase 1 | Czasami (5–29%) | W 1 chorobie |
| BBIP1BBSome interacting protein 1 | Czasami (5–29%) | W 1 chorobie |
| BBS1Bardet-Biedl syndrome 1 | Czasami (5–29%) | W 1 chorobie |
| BBS10Bardet-Biedl syndrome 10 | Czasami (5–29%) | W 1 chorobie |
| BBS2Bardet-Biedl syndrome 2 | Czasami (5–29%) | W 1 chorobie |
| BBS4Bardet-Biedl syndrome 4 | Czasami (5–29%) | W 1 chorobie |
| BBS5Bardet-Biedl syndrome 5 | Czasami (5–29%) | W 1 chorobie |
| BBS7Bardet-Biedl syndrome 7 | Czasami (5–29%) | W 1 chorobie |
| BBS9Bardet-Biedl syndrome 9 | Czasami (5–29%) | W 1 chorobie |
| BCKDKbranched chain keto acid dehydrogenase kinase | Czasami (5–29%) | W 1 chorobie |
| BRAFB-Raf proto-oncogene, serine/threonine kinase | Czasami (5–29%) | W 2 chorobach |
| BRF1BRF1 general transcription factor IIIB subunit | Czasami (5–29%) | W 1 chorobie |
| CA2carbonic anhydrase 2 | Czasami (5–29%) | W 1 chorobie |
| CAMK2Acalcium/calmodulin dependent protein kinase II alpha | Czasami (5–29%) | W 1 chorobie |
| CASZ1castor zinc finger 1 | Czasami (5–29%) | W 1 chorobie |
| CCDC22CCC complex scaffolding subunit CCDC22 | Czasami (5–29%) | W 1 chorobie |
| CDC42cell division cycle 42 | Czasami (5–29%) | W 2 chorobach |
| CEP19centrosomal protein 19 | Czasami (5–29%) | W 1 chorobie |
| CEP290centrosomal protein 290 | Czasami (5–29%) | W 1 chorobie |
| CFAP418cilia and flagella associated protein 418 | Czasami (5–29%) | W 1 chorobie |
| CHD7chromodomain helicase DNA binding protein 7 | Czasami (5–29%) | W 2 chorobach |
| CHST14carbohydrate sulfotransferase 14 | Czasami (5–29%) | W 2 chorobach |
| COL18A1collagen type XVIII alpha 1 chain | Czasami (5–29%) | W 1 chorobie |
| CTLA4cytotoxic T-lymphocyte associated protein 4 | Czasami (5–29%) | W 1 chorobie |
| CTNNB1catenin beta 1 | Czasami (5–29%) | W 1 chorobie |
| DDB1damage specific DNA binding protein 1 | Czasami (5–29%) | W 1 chorobie |
| DDX6DEAD-box helicase 6 | Czasami (5–29%) | W 1 chorobie |
| DHCR77-dehydrocholesterol reductase | Czasami (5–29%) | W 2 chorobach |
| DLK1delta like non-canonical Notch ligand 1 | Czasami (5–29%) | W 1 chorobie |
| DPYSL5dihydropyrimidinase like 5 | Czasami (5–29%) | W 1 chorobie |
| DSEdermatan sulfate epimerase | Czasami (5–29%) | W 1 chorobie |
| EBPEBP cholestenol delta-isomerase | Czasami (5–29%) | W 2 chorobach |
| ERCC6ERCC excision repair 6, chromatin remodeling factor | Czasami (5–29%) | W 1 chorobie |
| ERCC8ERCC excision repair 8, CSA ubiquitin ligase complex subunit | Czasami (5–29%) | W 1 chorobie |
| EYA1EYA transcriptional coactivator and phosphatase 1 | Czasami (5–29%) | W 1 chorobie |
| FAM20CFAM20C golgi associated secretory pathway kinase | Czasami (5–29%) | W 1 chorobie |
| FGFR2fibroblast growth factor receptor 2 | Czasami (5–29%) | W 3 chorobach |
| FLI1Fli-1 proto-oncogene, ETS transcription factor | Czasami (5–29%) | W 1 chorobie |
| FOCADfocadhesin | Czasami (5–29%) | W 1 chorobie |
| FOXF1forkhead box F1 | Czasami (5–29%) | W 2 chorobach |
| G6PC3glucose-6-phosphatase catalytic subunit 3 | Czasami (5–29%) | W 1 chorobie |
| GABRDgamma-aminobutyric acid type A receptor subunit delta | Czasami (5–29%) | W 1 chorobie |
| GNB1G protein subunit beta 1 | Czasami (5–29%) | W 2 chorobach |
| GRIA3glutamate ionotropic receptor AMPA type subunit 3 | Czasami (5–29%) | W 1 chorobie |
| HDAC4histone deacetylase 4 | Czasami (5–29%) | W 1 chorobie |
| HLA-DPA1major histocompatibility complex, class II, DP alpha 1 | Czasami (5–29%) | W 1 chorobie |
| HLA-DPB1major histocompatibility complex, class II, DP beta 1 | Czasami (5–29%) | W 1 chorobie |
| HOXD13homeobox D13 | Czasami (5–29%) | W 1 chorobie |
| HSPG2heparan sulfate proteoglycan 2 | Czasami (5–29%) | W 1 chorobie |
| IFT172intraflagellar transport 172 | Czasami (5–29%) | W 1 chorobie |
| IFT27intraflagellar transport 27 | Czasami (5–29%) | W 2 chorobach |
| IFT56intraflagellar transport 56 | Czasami (5–29%) | W 1 chorobie |
| IFT74intraflagellar transport 74 | Czasami (5–29%) | W 1 chorobie |
| IPO8importin 8 | Czasami (5–29%) | W 1 chorobie |
| KAT6Alysine acetyltransferase 6A | Czasami (5–29%) | W 2 chorobach |
| KCNAB2potassium voltage-gated channel subfamily A regulatory beta subunit 2 | Czasami (5–29%) | W 1 chorobie |
| KDM6Alysine demethylase 6A | Czasami (5–29%) | W 2 chorobach |
| KMT2Dlysine methyltransferase 2D | Czasami (5–29%) | W 2 chorobach |
| KRASKRas proto-oncogene, GTPase | Czasami (5–29%) | W 2 chorobach |
| LAMA3laminin subunit alpha 3 | Czasami (5–29%) | W 1 chorobie |
| LAMB3laminin subunit beta 3 | Czasami (5–29%) | W 1 chorobie |
| LAMC2laminin subunit gamma 2 | Czasami (5–29%) | W 1 chorobie |
| LMNB1lamin B1 | Czasami (5–29%) | W 1 chorobie |
| LUZP1leucine zipper protein 1 | Czasami (5–29%) | W 1 chorobie |
| LZTFL1leucine zipper transcription factor like 1 | Czasami (5–29%) | W 1 chorobie |
| MAP2K1mitogen-activated protein kinase kinase 1 | Czasami (5–29%) | W 2 chorobach |
| MAP2K2mitogen-activated protein kinase kinase 2 | Czasami (5–29%) | W 2 chorobach |
| MBTPS2membrane bound transcription factor peptidase, site 2 | Czasami (5–29%) | W 1 chorobie |
| MED11mediator complex subunit 11 | Czasami (5–29%) | W 1 chorobie |
| MED25mediator complex subunit 25 | Czasami (5–29%) | W 2 chorobach |
| MEG3maternally expressed 3 | Czasami (5–29%) | W 1 chorobie |
| MIA3MIA SH3 domain ER export factor 3 | Czasami (5–29%) | W 1 chorobie |
| MID1midline 1 | Czasami (5–29%) | W 1 chorobie |
| MKS1MKS transition zone complex subunit 1 | Czasami (5–29%) | W 1 chorobie |
| MMP23Bmatrix metallopeptidase 23B | Czasami (5–29%) | W 1 chorobie |
| MYMKmyomaker, myoblast fusion factor | Czasami (5–29%) | W 1 chorobie |
| MYMXmyomixer, myoblast fusion factor | Czasami (5–29%) | W 1 chorobie |
| NDUFAF3NADH:ubiquinone oxidoreductase complex assembly factor 3 | Czasami (5–29%) | W 1 chorobie |
| NPHP1nephrocystin 1 | Czasami (5–29%) | W 1 chorobie |
| NRIP1nuclear receptor interacting protein 1 | Czasami (5–29%) | W 1 chorobie |
| NSD1nuclear receptor binding SET domain protein 1 | Czasami (5–29%) | W 2 chorobach |
| NXNnucleoredoxin | Czasami (5–29%) | W 1 chorobie |
| OFD1OFD1 centriole and centriolar satellite protein | Czasami (5–29%) | W 1 chorobie |
| OTUD5OTU deubiquitinase 5 | Czasami (5–29%) | W 1 chorobie |
| PAX7paired box 7 | Czasami (5–29%) | W 1 chorobie |
| PDPNpodoplanin | Czasami (5–29%) | W 1 chorobie |
| PGAP2post-GPI attachment to proteins 2 | Czasami (5–29%) | W 1 chorobie |
| PGAP3post-GPI attachment to proteins phospholipase 3 | Czasami (5–29%) | W 1 chorobie |
| PGM1phosphoglucomutase 1 | Czasami (5–29%) | W 1 chorobie |
| PIEZO2piezo type mechanosensitive ion channel component 2 | Czasami (5–29%) | W 1 chorobie |
| PIGLphosphatidylinositol glycan anchor biosynthesis class L | Czasami (5–29%) | W 3 chorobach |
| PIGNphosphatidylinositol glycan anchor biosynthesis class N | Czasami (5–29%) | W 3 chorobach |
| PIGOphosphatidylinositol glycan anchor biosynthesis class O | Czasami (5–29%) | W 1 chorobie |
| PIGVphosphatidylinositol glycan anchor biosynthesis class V | Czasami (5–29%) | W 1 chorobie |
| PIGWphosphatidylinositol glycan anchor biosynthesis class W | Czasami (5–29%) | W 1 chorobie |
| PIGYphosphatidylinositol glycan anchor biosynthesis class Y | Czasami (5–29%) | W 1 chorobie |
| PLECplectin | Czasami (5–29%) | W 1 chorobie |
| PPFIA3PPFI scaffold protein A3 | Czasami (5–29%) | W 1 chorobie |
| PRDM16PR/SET domain 16 | Czasami (5–29%) | W 1 chorobie |
| PRKCZprotein kinase C zeta | Czasami (5–29%) | W 1 chorobie |
| PRTN3proteinase 3 | Czasami (5–29%) | W 1 chorobie |
| PTPN22protein tyrosine phosphatase non-receptor type 22 | Czasami (5–29%) | W 1 chorobie |
| RAB18RAB18, member RAS oncogene family | Czasami (5–29%) | W 1 chorobie |
| RAB3GAP1RAB3 GTPase activating protein catalytic subunit 1 | Czasami (5–29%) | W 1 chorobie |
| RAB3GAP2RAB3 GTPase activating non-catalytic protein subunit 2 | Czasami (5–29%) | W 1 chorobie |
| RBM10RNA binding motif protein 10 | Czasami (5–29%) | W 2 chorobach |
| RECQL4RecQ like helicase 4 | Czasami (5–29%) | W 1 chorobie |
| REREarginine-glutamic acid dipeptide repeats | Czasami (5–29%) | W 1 chorobie |
| RFX7regulatory factor X7 | Czasami (5–29%) | W 1 chorobie |
| RORARAR related orphan receptor A | Czasami (5–29%) | W 1 chorobie |
| RTL1retrotransposon Gag like 1 | Czasami (5–29%) | W 1 chorobie |
| SCAF4SR-related CTD associated factor 4 | Czasami (5–29%) | W 1 chorobie |
| SCAPERS-phase cyclin A associated protein in the ER | Czasami (5–29%) | W 1 chorobie |
| SCARF2scavenger receptor class F member 2 | Czasami (5–29%) | W 1 chorobie |
| SCLT1sodium channel and clathrin linker 1 | Czasami (5–29%) | W 1 chorobie |
| SDCCAG8SHH signaling and ciliogenesis regulator SDCCAG8 | Czasami (5–29%) | W 1 chorobie |
| SEMA3Esemaphorin 3E | Czasami (5–29%) | W 1 chorobie |
| SIX1SIX homeobox 1 | Czasami (5–29%) | W 1 chorobie |
| SIX5SIX homeobox 5 | Czasami (5–29%) | W 1 chorobie |
| SKISKI proto-oncogene | Czasami (5–29%) | W 1 chorobie |
| SOS1SOS Ras/Rac guanine nucleotide exchange factor 1 | Czasami (5–29%) | W 1 chorobie |
| SOX9SRY-box transcription factor 9 | Czasami (5–29%) | W 2 chorobach |
| SPENspen family transcriptional repressor | Czasami (5–29%) | W 1 chorobie |
| SRCAPSnf2 related CREBBP activator protein | Czasami (5–29%) | W 2 chorobach |
| TASP1taspase 1 | Czasami (5–29%) | W 1 chorobie |
| TBC1D20TBC1 domain family member 20 | Czasami (5–29%) | W 1 chorobie |
| TBX1T-box transcription factor 1 | Czasami (5–29%) | W 2 chorobach |
| TBX18T-box transcription factor 18 | Czasami (5–29%) | W 1 chorobie |
| TFAP2Atranscription factor AP-2 alpha | Czasami (5–29%) | W 1 chorobie |
| TOGARAM1TOG array regulator of axonemal microtubules 1 | Czasami (5–29%) | W 1 chorobie |
| TRIM32tripartite motif containing 32 | Czasami (5–29%) | W 1 chorobie |
| TRRAPtransformation/transcription domain associated protein | Czasami (5–29%) | W 1 chorobie |
| TTC8tetratricopeptide repeat domain 8 | Czasami (5–29%) | W 1 chorobie |
| UBE4Bubiquitination factor E4B | Czasami (5–29%) | W 1 chorobie |
| UBR1ubiquitin protein ligase E3 component n-recognin 1 | Czasami (5–29%) | W 2 chorobach |
| USP9Xubiquitin specific peptidase 9 X-linked | Czasami (5–29%) | W 2 chorobach |
| VPS35LVPS35 endosomal protein sorting factor like | Czasami (5–29%) | W 1 chorobie |
| WASHC5WASH complex subunit 5 | Czasami (5–29%) | W 2 chorobach |
| WBP4WW domain binding protein 4 | Czasami (5–29%) | W 1 chorobie |
| WDPCPWD repeat containing planar cell polarity effector | Czasami (5–29%) | W 1 chorobie |
| WLSWnt ligand secretion mediator | Czasami (5–29%) | W 1 chorobie |
| YY1YY1 transcription factor | Czasami (5–29%) | W 2 chorobach |
| ZEB2zinc finger E-box binding homeobox 2 | Czasami (5–29%) | W 2 chorobach |
| ZFXzinc finger protein X-linked | Czasami (5–29%) | W 1 chorobie |
| ZMYM2zinc finger MYM-type containing 2 | Czasami (5–29%) | W 1 chorobie |
| APC2APC regulator of Wnt signaling pathway 2 | Rzadko (1–4%) | W 1 chorobie |
| ATN1atrophin 1 | Rzadko (1–4%) | W 1 chorobie |
| ATP6V1B2ATPase H+ transporting V1 subunit B2 | Rzadko (1–4%) | W 1 chorobie |
| EHMT1euchromatic histone lysine methyltransferase 1 | Rzadko (1–4%) | W 1 chorobie |
| FGF10fibroblast growth factor 10 | Rzadko (1–4%) | W 1 chorobie |
| FGFR3fibroblast growth factor receptor 3 | Rzadko (1–4%) | W 1 chorobie |
| GREB1LGREB1 like retinoic acid receptor coactivator | Rzadko (1–4%) | W 1 chorobie |
| NF1neurofibromin 1 | Rzadko (1–4%) | W 1 chorobie |
| NSDHLNAD(P) dependent 3-beta-hydroxysteroid dehydrogenase NSDHL | Rzadko (1–4%) | W 2 chorobach |
| PORCNporcupine O-acyltransferase | Rzadko (1–4%) | W 2 chorobach |
| SPARTspartin | Rzadko (1–4%) | W 1 chorobie |
| TBC1D24TBC1 domain family member 24 | Rzadko (1–4%) | W 1 chorobie |
| ARID1BAT-rich interaction domain 1B | Nie odnotowano | W 1 chorobie |
| ARPC4actin related protein 2/3 complex subunit 4 | Nie odnotowano | W 1 chorobie |
| ATP7AATPase copper transporting alpha | Nie odnotowano | W 1 chorobie |
| B4GAT1beta-1,4-glucuronyltransferase 1 | Nie odnotowano | W 1 chorobie |
| CCBE1collagen and calcium binding EGF domains 1 | Nie odnotowano | W 1 chorobie |
| CENPFcentromere protein F | Nie odnotowano | W 1 chorobie |
| CHRM3cholinergic receptor muscarinic 3 | Nie odnotowano | W 1 chorobie |
| CRTAPcartilage associated protein | Nie odnotowano | W 1 chorobie |
| DVL1dishevelled segment polarity protein 1 | Nie odnotowano | W 1 chorobie |
| ERBB3erb-b2 receptor tyrosine kinase 3 | Nie odnotowano | W 1 chorobie |
| FGFR1fibroblast growth factor receptor 1 | Nie odnotowano | W 1 chorobie |
| GLI3GLI family zinc finger 3 | Nie odnotowano | W 1 chorobie |
| HYLS1HYLS1 centriolar and ciliogenesis associated | Nie odnotowano | W 1 chorobie |
| KANSL1KAT8 regulatory NSL complex subunit 1 | Nie odnotowano | W 1 chorobie |
| MASP1MBL associated serine protease 1 | Nie odnotowano | W 1 chorobie |
| NBNnibrin | Nie odnotowano | W 1 chorobie |
| PLD1phospholipase D1 | Nie odnotowano | W 1 chorobie |
| RAB23RAB23, member RAS oncogene family | Nie odnotowano | W 1 chorobie |
| SALL4spalt like transcription factor 4 | Nie odnotowano | W 1 chorobie |
| SHHsonic hedgehog signaling molecule | Nie odnotowano | W 1 chorobie |
| STRA6signaling receptor and transporter of retinol STRA6 | Nie odnotowano | W 1 chorobie |
| TAPT1transmembrane anterior posterior transformation 1 | Nie odnotowano | W 1 chorobie |
| TBX15T-box transcription factor 15 | Nie odnotowano | W 1 chorobie |
| WNT5AWnt family member 5A | Nie odnotowano | W 1 chorobie |
| XDHxanthine dehydrogenase | Nie odnotowano | W 1 chorobie |
| ZIC3Zic family zinc finger 3 | Nie odnotowano | W 1 chorobie |
Jak często występuje wśród osób z jedną z chorób związanych z tym genem, najczęściej spośród wszystkich, według danych Human Phenotype Ontology. Te strony opisują cechy i badania, na których się opierają; nie są diagnozą, a w sprawie objawów należy zwrócić się do lekarza lub doradcy genetycznego.
Cechy nadrzędne
Skąd pochodzą te dane
- Human Phenotype Ontology, wydanie 2026-09-01: cecha, jej nazwy, definicja oraz geny z nią powiązane. Więcej informacji znajdą Państwo na stronie hpo.jax.org.
- Wydanie danych 2026.10.16-c6eea6bf.
Jeden test. Odpowiedzi na całe życie.
Od 449 $Bezpłatna wysyłka · Wyniki w ciągu 6–8 tygodni